Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00332
Species: Homo sapiens
Position : chr11:5301549-5302549
Year: 2020
Title: Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: chronic myeloid leukemia
PMID:  31980609
MONDO: MONDO:0011998
Tissue: Blood
Tissue Ontology ID: UBERON:0000178
Cell Source: K562 erythroleukemia
CVCL ID: CVCL_0004
Cell Type: chronic myeloid leukemia cell
Cell Ontology ID: CL:0001054
Experiment Type: Enhancer activity assay, Functional perturbation assay, TF binding assay
High Throughput Method: ChIP-seq, RNA-seq, ATAC-seq
Low Throughput Method: CRISPRi, CRISPRa, RT-RT-qPCR, Western blot
About Target Gene
Target gene : HBE1
About TF
TF name : GATA1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
GATA1 C-MYB transcription factor network pid 87
GATA1 Factors involved in megakaryocyte development and platelet production reactome 111
GATA1 IL3 netpath 84
GATA1 Notch-mediated HES/HEY network pid 48
GATA1 p73 transcription factor network pid 80
GATA1 Signaling events mediated by HDAC Class I pid 89
GATA1 Signaling events mediated by HDAC Class II pid 58
Enhancer Associated Network
Overlapping Enhancers (hg19) 4 found
Enhancer ID Position Tissue Cell Disease
E_00234 chr11:5301549-5302549 Liver hepatocellular carcinoma cell hepatocellular carcinoma
E_00321 chr11:5301549-5302549 Blood chronic myeloid leukemia cell chronic myeloid leukemia
E_00323 chr11:5301549-5302549 Peripheral Blood T cell adult T-cell leukemia/lymphoma
E_00340 chr11:5301862-5302715 Hematopoietic system chronic myeloid leukemia cell chronic myeloid leukemia
Expression of Target Genes for the Enhancer